Compare SCLX & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | BDL |
|---|---|---|
| Founded | 2011 | 1959 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.9M | 62.6M |
| IPO Year | N/A | 1995 |
| Metric | SCLX | BDL |
|---|---|---|
| Price | $6.57 | $31.00 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 30.1K | 895.0 |
| Earning Date | 05-13-2026 | 02-10-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | N/A | ★ 49.72 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $205,248,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $749.70 | N/A |
| P/E Ratio | ★ N/A | $72.56 |
| Revenue Growth | N/A | ★ 8.99 |
| 52 Week Low | $0.18 | $22.61 |
| 52 Week High | $34.27 | $35.98 |
| Indicator | SCLX | BDL |
|---|---|---|
| Relative Strength Index (RSI) | 30.61 | 43.77 |
| Support Level | $4.56 | $29.56 |
| Resistance Level | $7.50 | $33.12 |
| Average True Range (ATR) | 0.64 | 0.61 |
| MACD | -0.13 | -0.35 |
| Stochastic Oscillator | 0.00 | 0.00 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.